Walled Lake Planning & Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Walled Lake Planning & Wealth Management, LLC

  • $246 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 19, 2021
SELL
$478.3 - $607.98 $139,663 - $177,530
-292 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $26,148 - $31,594
-48 Reduced 14.12%
292 $163,000
Q2 2020

Aug 18, 2020
SELL
$493.32 - $643.92 $138,129 - $180,297
-280 Reduced 45.16%
340 $212,000
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $110,939 - $163,161
-330 Reduced 34.74%
620 $303,000
Q4 2019

May 15, 2020
BUY
$274.13 - $376.51 $260,423 - $357,684
950 New
950 $357,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Walled Lake Planning & Wealth Management, LLC Portfolio

Follow Walled Lake Planning & Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walled Lake Planning & Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walled Lake Planning & Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email